Form 4: Guardant Health CEO Sells Shares
Insider Transaction (Form 4)
Amirali Talasaz, Co-Chief Executive Officer and a Director of Guardant Health, Inc., sold 37,500 shares of common stock on August 21, 2026.
Summary
- Open-market sale: disposed of 9,023 Common Stock at $168.20 ($1,517,631) on August 21, 2026; holds 65,977 after (Indirect).
- Open-market sale: disposed of 20,888 Common Stock at $169.16 ($3,533,452) on August 21, 2026; holds 45,089 after (Indirect).
- Open-market sale: disposed of 7,589 Common Stock at $170.29 ($1,292,302) on August 21, 2026; holds 37,500 after (Indirect).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $6,343,384 of stock on the open market.
Insider Transactions
Amirali Talasaz — Director, Officer (Co-Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Open-market sale | Common Stock | 9,023 | $168 | $1.5M | 65,977 |
| 2026-08-21 | Open-market sale | Common Stock | 20,888 | $169 | $3.5M | 45,089 |
| 2026-08-21 | Open-market sale | Common Stock | 7,589 | $170 | $1.3M | 37,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Open-market sale (9,023 shares) |
| 2026-08-21 | Open-market sale (20,888 shares) |
| 2026-08-21 | Open-market sale (7,589 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., bearish, Amirali Talasaz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.